GlassScriptPhysician profile
Sean M Lee
NPI 1295901312
$9,726.49
in general payments reported to CMS, 2019-2025
10 companies · $872 in 2025
The $872 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $400 · 2020: $258 · 2021: $535 · 2022: $3,096 · 2023: $3,167 · 2024: $1,400 · 2025: $872.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,045 · Travel and Lodging: $1,017 · Food and Beverage: $1,002 · Consulting Fee: $375.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,044.50 |
| Travel and Lodging | $1,017.12 |
| Food and Beverage | $1,001.84 |
| Consulting Fee | $375.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,110.47 | 2019-2024 | Davinci Xi, Da Vinci Surgical System |
| Medtronic, INC. | $1,409.38 | 2022-2024 | Ligasure |
| W. L. Gore & Associates, INC. | $1,144.06 | 2019-2025 | Gore Enform Preperitoneal Biomaterial, Gore Synecor Biomaterial, Seamguard Staple Line Reinforcement |
| Ethicon US, LLC | $451.21 | 2019-2025 | Echelon; Endopath, Echelon Circular, Harmonic |
| Applied Medical Resources Corporation | $375.00 | 2025 | |
| Janssen Biotech, INC. | $104.44 | 2025 | Tremfya |
| Tela Bio, INC. | $62.35 | 2024 | Ovitex 2s |
| Covidien LP | $30.21 | 2019 | |
| Microline Surgical INC | $22.98 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $16.39 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sean Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.